Viking Therapeutics (NASDAQ: VKTX) said VK2735 maintained up to 97% of weight loss after subjects moved to every-other-week dosing. Monthly dosing preserved up to 90% of weight loss. The results came from a 12-week maintenance study of the GLP-1/GIP agonist. Weekly dosing at 17.5 …
Beam Global (NASDAQ: BEEM) is an electrical products company. It signed a non-binding letter of intent to acquire a European drone technology company, a proposed transaction that would expand its activities into drones and AI-enhanced drone software. Completion remains conditional on due diligence, negotiations, …
Harvard Bioscience Inc (NASDAQ: HBIO) has a 5.2% ownership position held by Leviticus Partners LP. The reported interest covers 235,000 common shares.
Immuron Ltd (NASDAQ: IMRN), a Pharmaceuticals: Major company, says its $9 million cash balance is sufficient to fund commercial operations. TheBusinessis pursuing a strategic reset that places IMM-124E and IMM-529 with partners for development and commercialization.
Immutep Limited (NASDAQ: IMMP) is a biotechnology company. Its ADS count is expected to move from approximately 32.8 million to approximately 1.64 million when a revised ADS ratio takes effect on September 28, 2026. The change is aimed at helping the Nasdaq-listed ADSs meet …
Sovargen Trial Reaches First-Patient Milestone
The milestone extends paxalisib development beyond oncology into intractable epilepsy associated with focal cortical dysplasia and tuberous sclerosis complex.
Alibaba Group Holding Limited’s activist stake in ZTO Express (Cayman) Inc. (NYSE: ZTO) fell to 6.1%, representing 46,941,287 Class A ordinary shares (46.9 million). The position is reported under Schedule 13D, which identifies activist rather than passive ownership intent. The change was recorded on …
Adagene Inc. received China’s NMPA clearance for ADG138’s investigational new drug application, with a first-in-human Phase 1 study in advanced solid tumors expected in the fourth quarter of 2026. The study is designed to assess safety, preliminary efficacy and the recommended dose for Phase …
Advanced Biomed Inc. (NASDAQ: ADVB) is a biotechnology company. Advance On Ventures Limited holds 109,200 shares of Advanced Biomed common stock, representing 6.6% ownership.